Workflow
Halozyme Therapeutics: Still Undervalued Ahead Of Earnings
HALOHalozyme(HALO) Seeking Alpha·2025-05-01 21:06

I've been investing for over 7 years with a focus on long term wealth creation through value growth investing, value investing, and dividend investing. I'm not a financial advisor or financial planner. I do not have a formal background in finance, I have a B.S. in Biology with a concentration in molecular cell biology. However, I am an avid reader, studier, and learner and have applied my rigorous undergraduate studies and research to investing. I plan to write articles on companies through the lens of fund ...